1. Volume 59, Issue 3, Pages 438-446 (March 2011)
Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette- Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993) 
Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, Fernando Calais da Silva, Christer Busch, Ferran Algaba, Sandra Collette, Aldo Bono 
European Urology 
Volume 59, Issue 3, Pages (March 2011)
DOI: /j.eururo
Copyright © 2010 European Association of Urology Terms and Conditions

2. Fig. 1 Treatment schedule.
BCG=bacillus Calmette-Guérin; MMC=mitomycin C; TUR=transurethral resection.
European Urology  , DOI: ( /j.eururo )
Copyright © 2010 European Association of Urology Terms and Conditions

3. Fig. 2 Consolidated Standards of Reporting Trials (CONSORT) diagram.
BCG=bacillus Calmette-Guérin; CIS=carcinoma in situ; MMC=mitomycin C; TUR=transurethral resection.
European Urology  , DOI: ( /j.eururo )
Copyright © 2010 European Association of Urology Terms and Conditions

4. Fig. 3
Time to recurrence.
BCG=bacillus Calmette-Guérin; MMC=mitomycin C.
European Urology  , DOI: ( /j.eururo )
Copyright © 2010 European Association of Urology Terms and Conditions

5. Fig. 4 Duration of survival.
BCG=bacillus Calmette-Guérin; MMC=mitomycin C.
European Urology  , DOI: ( /j.eururo )
Copyright © 2010 European Association of Urology Terms and Conditions

6. Fig. 5 Time to recurrence in complete responders.
BCG=bacillus Calmette-Guérin; MMC=mitomycin C.
European Urology  , DOI: ( /j.eururo )
Copyright © 2010 European Association of Urology Terms and Conditions